Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xenical for Steatosis/NASH in HCV Patients
NCT00207311Phase 4Completed
- Sponsor
- Brooke Army Medical Center
- Start
- Aug 2005
- Primary completion
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Nonalcoholic steatohepatitis (NASH) and hepatic steatosis comparing Xenical (orlistat) with Xenical placebo (2 arms). Primary endpoint: Sustained Virological Response. Started Aug 2005; status: completed.
02
Drugs
orlistat
03
Conditions
Nonalcoholic steatohepatitis (NASH)hepatic steatosis
Beyond the preview
Go deeper on NCT00207311.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00207311.